Insider trading

Period: 120 months Stock: ALEC Minimum amount: $1M × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

36 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

36 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

36 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

36 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
36 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
36 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

36 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Sep 2023
MCGUIRE TERRANCE Director · indirect
Sold at will
$3.00M 500,000 at 6.00
4.4%
Not planned
11 Sep 2023
Sold at will
$3.00M 500,000 at 6.00
4.4%
Not planned
13 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.59M 75,000 at 21.24
42.2%
10 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.63M 75,000 at 21.76
42.2%
9 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.71M 75,000 at 22.82
42.2%
8 Dec 2021
SULIMAN SHEHNAAZ President and COO
Sold, plan not stated 2×
$1.71M 75,000 at 22.79
42.2%
11 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated
$1.38M 55,000 at 25.00
2.7%
10 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated
$1.38M 55,000 at 25.00
2.6%
9 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
13.3%
8 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
13.0%
5 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
12.8%
4 Nov 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 4×
$2.50M 100,000 at 25.00
12.5%
22 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 2×
$2.53M 100,000 at 25.33
4.1%
21 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 2×
$2.61M 100,000 at 26.11
4.0%
20 Sep 2021
Rosenthal Arnon Chief Executive Officer · indirect
Sold, plan not stated 2×
$2.58M 100,000 at 25.80
3.8%
5 Aug 2021
Sold, plan not stated 2×
$1.56M 56,260 at 27.68
100%
Sold half or more
7 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 3×
$1.15M 29,749 at 38.70
11.3%
6 Jul 2021
Paul Robert Chief Medical Officer
Sold, plan not stated 6×
$1.12M 30,000 at 37.31
11.3%
2 Jul 2021
Yu Calvin Vice President, Finance
Sold, plan not stated 2×
$3.63M 110,840 at 32.74
59.1%
Sold half or more
2 Jul 2021
King Robert Chief Development Officer
Sold, plan not stated
$1.87M 60,000 at 31.14
10.3%
16 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.46M 62,183 at 23.53
3.2%
9 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$6.85M 288,101 at 23.79
13.0%
8 Apr 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.95M 82,614 at 23.65
4.0%
31 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$6.13M 250,000 at 24.50
11.0%
25 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.39M 56,411 at 24.66
2.6%
24 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$1.65M 67,644 at 24.45
3.1%
2 Mar 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$48.73M 1,874,203 at 26.00
100%
Sold half or more
4 Feb 2020
Yu Calvin Vice President, Finance
Sold, plan not stated
$1.91M 63,541 at 30.04
33.6%
9 Jan 2020
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$7.41M 379,997 at 19.50
90.7%
Sold half or more
24 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$1.41M 71,800 at 19.59
63.4%
Sold half or more
23 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$1.87M 94,285 at 19.82
65.6%
Sold half or more
20 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$6.73M 342,500 at 19.66
85.1%
Sold half or more
17 Dec 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 3×
$17.67M 954,100 at 18.52
90.7%
Sold half or more
7 Aug 2019
ORBIMED ADVISORS LLC 10% owner · indirect
Sold, plan not stated 2×
$11.64M 650,000 at 17.90
18.0%
11 Feb 2019
ORBIMED ADVISORS LLC Director · indirect
Bought 3×
$7.82M 411,700 at 19.00
4.1%
First buy on file
11 Feb 2019
GORDON CARL L Director · indirect
Bought 3×
$7.82M 411,700 at 19.00
4.1%
First buy on file
Showing 1–36 of 36.